Amicus Therapeutics, Inc. - stock earnings
FOLD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -33.8 million USD | 115.1 million USD |
| 2023Q3 | -21.6 million USD | 103.5 million USD |
| 2023Q2 | -43.2 million USD | 94.5 million USD |
| 2023Q1 | -52.9 million USD | 86.3 million USD |
| 2022Q4 | -55.9 million USD | 88.1 million USD |
| 2022Q3 | -33.3 million USD | 81.7 million USD |
| 2022Q2 | -62.2 million USD | 80.7 million USD |
| 2022Q1 | -85.3 million USD | 78.7 million USD |
| 2021Q4 | -83.3 million USD | 82.2 million USD |
| 2021Q3 | -50.3 million USD | 79.5 million USD |
| 2021Q2 | -51.2 million USD | 77.4 million USD |
| 2021Q1 | -65.7 million USD | 66.4 million USD |
| 2020Q4 | -71.4 million USD | 70.6 million USD |
| 2020Q3 | -64.0 million USD | 67.4 million USD |
| 2020Q2 | -52.5 million USD | 62.4 million USD |
| 2020Q1 | -88.9 million USD | 60.5 million USD |
| 2019Q4 | -89.7 million USD | 55.3 million USD |
| 2019Q3 | -61.8 million USD | 48.8 million USD |
| 2019Q2 | -84.6 million USD | 44.1 million USD |
| 2019Q1 | -120.3 million USD | 34.0 million USD |
| 2018Q4 | -78.1 million USD | 32.6 million USD |
| 2018Q3 | -159.2 million USD | 20.6 million USD |
| 2018Q2 | -61.8 million USD | 21.3 million USD |
| 2018Q1 | -49.9 million USD | 16.7 million USD |
| 2017Q4 | -69.2 million USD | 14.7 million USD |
| 2017Q3 | -111.7 million USD | 10.9 million USD |
| 2017Q2 | -48.1 million USD | 7.2 million USD |
| 2017Q1 | -55.0 million USD | 4.2 million USD |
| 2016Q4 | -58.6 million USD | 2.8 million USD |
| 2016Q3 | -46.7 million USD | 2.1 million USD |
| 2016Q2 | -51.1 million USD | ? USD |
| 2016Q1 | -43.7 million USD | ? USD |
| 2015Q4 | -42.9 million USD | ? USD |
| 2015Q3 | -37.8 million USD | ? USD |
| 2015Q2 | -27.1 million USD | ? USD |
| 2015Q1 | -24.3 million USD | ? USD |
| 2014Q4 | -21.2 million USD | -1.2 million USD |
| 2014Q3 | -17.1 million USD | 293000 USD |
| 2014Q2 | -14.6 million USD | 475000 USD |
| 2014Q1 | -15.9 million USD | 456000 USD |
| 2013Q4 | -12.2 million USD | 324000 USD |
| 2013Q3 | -14.6 million USD | 39000 USD |
| 2013Q2 | -15.3 million USD | ? USD |
| 2013Q1 | -17.5 million USD | ? USD |
| 2012Q4 | -10.0 million USD | 18.4 million USD |
| 2012Q3 | -16.3 million USD | 5.8 million USD |
| 2012Q2 | -9.3 million USD | 10.6 million USD |
| 2012Q1 | -13.1 million USD | 7.8 million USD |
| 2011Q4 | -8.7 million USD | 5.6 million USD |
| 2011Q3 | -9.8 million USD | 5.8 million USD |
| 2011Q2 | -12.6 million USD | 4.0 million USD |
| 2011Q1 | -13.4 million USD | 6.0 million USD |
| 2010Q4 | -15.1 million USD | 922000 USD |
| 2010Q3 | -15.4 million USD | ? USD |
| 2010Q2 | -11.3 million USD | ? USD |
| 2010Q1 | -13.2 million USD | 49.5 million USD |
| 2009Q4 | 33.0 million USD | 49.5 million USD |
| 2009Q3 | -13.4 million USD | 4.9 million USD |
| 2009Q2 | -13.6 million USD | 5.4 million USD |
| 2009Q1 | -12.5 million USD | 4.6 million USD |
| 2008Q4 | -14.2 million USD | 4.3 million USD |
| 2008Q3 | -8.2 million USD | 3.7 million USD |
| 2008Q2 | -9.3 million USD | 3.8 million USD |
| 2008Q1 | -7.7 million USD | 3.2 million USD |
| 2007Q4 | -11.8 million USD | 1.8 million USD |
| 2007Q3 | -10.3 million USD | ? USD |
| 2007Q2 | -9.4 million USD | ? USD |
| 2007Q1 | -9.7 million USD | ? USD |
| 2006Q4 | -11.6 million USD | ? USD |
| 2006Q3 | -11.6 million USD | ? USD |
| 2006Q2 | -11.6 million USD | ? USD |
| 2006Q1 | -11.6 million USD | ? USD |
| 2005Q4 | -5.0 million USD | ? USD |
| 2005Q3 | -5.0 million USD | ? USD |
| 2005Q2 | -5.0 million USD | ? USD |
| 2005Q1 | -5.0 million USD | ? USD |
FOLD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -151.6 million USD | 399.4 million USD |
| 2022 | -236.6 million USD | 329.2 million USD |
| 2021 | -250.5 million USD | 305.5 million USD |
| 2020 | -276.9 million USD | 260.9 million USD |
| 2019 | -356.4 million USD | 182.2 million USD |
| 2018 | -349.0 million USD | 91.2 million USD |
| 2017 | -284.0 million USD | 36.9 million USD |
| 2016 | -200.0 million USD | 5.0 million USD |
| 2015 | -132.1 million USD | ? USD |
| 2014 | -68.9 million USD | 1.2 million USD |
| 2013 | -59.6 million USD | 363000 USD |
| 2012 | -48.8 million USD | 18.4 million USD |
| 2011 | -44.4 million USD | 21.4 million USD |
| 2010 | -54.9 million USD | 922000 USD |
| 2009 | -6.6 million USD | 64.4 million USD |
| 2008 | -39.4 million USD | 15.0 million USD |
| 2007 | -41.2 million USD | 1.8 million USD |
| 2006 | -46.3 million USD | ? USD |
| 2005 | -20.0 million USD | ? USD |
| 2004 | -8.8 million USD | ? USD |
| 2003 | -6.8 million USD | ? USD |
FOLD
Price: $10.40
52 week price:
Earnings Per Share: -0.51 USD
P/E Ratio: -22
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.4 million
Ebitda: -271.1 millionMarket Capitalization: 3.2 billion